Learn how different organizations are approaching using AI/ML, their thoughts on the challenges and opportunities with regulatory acceptance of approaches in drug development, how these efforts can improve clinical trial diversity, and what we need to move forward.
Moderator
Senior Director, Science & Regulatory Affairs
Biotechnology Innovation Organization
Speakers
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
